Accurate determination of left ventricular mass and left ventricular systolic volume and function is important for assessment of prognosis and therapeutic options in patients with hypertensive heart disease, coronary heart disease and congestive heart failure [1, 2] .
In patients with hypertension, left ventricular hypertrophy increases the relative risk of mortality by twofold in those patients who also have coronary artery disease and by fourfold in those patients with normal coronary arteries [3] . Because of the low cost, M-mode echocardiography is the most widely used method to determine left ventricular mass [4] . However, there is considerable variability for repeated measurements. Two-dimensional and 3-dimensional echocardiography is more used for determination of left ventricular volumes and left ventricular ejection fraction, with an excellent intra-observer variability but worse inter-observer variability [ 
